Exforge gets U.S. approval, Novartis says

Swiss drugmaker Novartis AG said its Exforge antihypertensive medication has recently received approval from the U.S. Food and Drug Administration (FDA).

Exforge combines valsartan and amlodipine besylate in one pill.

"Exforge is expected to be available to patients in the U.S. in late September 2007, pending the expiration of market exclusivity and patent protection for amlodipine besyl...